Algert Global’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Algert Global’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-124,891	Closed	-$85K	–	429
2015 Q4	$85K	Hold	124,891	–	–	0.04%	321
2015 Q3	$121K	Hold	124,891	–	–	0.07%	294
2015 Q2	$150K	Hold	124,891	–	–	0.08%	293
2015 Q1	$132K	Hold	124,891	–	–	0.07%	293
2014 Q4	$136K	Hold	124,891	–	–	0.08%	271
2014 Q3	$135K	Hold	124,891	–	–	0.1%	255
2014 Q2	$130K	Hold	124,891	–	–	0.08%	270
2014 Q1	$129K	Hold	124,891	–	–	0.05%	292
2013 Q4	$145K	Hold	124,891	–	–	0.04%	333
2013 Q3	$210K	Hold	124,891	–	–	0.06%	307
2013 Q2	$250K	Buy	+124,891	New	+$366K	0.08%	238

Other funds holding ENZN

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Algert Global's ENZN Position: Q1 2016 in Review

Algert Global sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2016, closing a stake of 124,891 shares — an estimated $85K sold.

Algert Global first reported a position in ENZN in Q2 2013 and held it in 11 quarters. The position peaked at $250K in Q2 2013. 40 funds tracked by Wall St. Rank hold ENZN as of Q1 2016.

Algert Global reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2016 after selling out during the quarter.
Algert Global sold 124,891 ENZON PHARMACEUTICALS INC shares in Q1 2016, an estimated $85K.
Algert Global first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 11 quarters.
Algert Global's ENZON PHARMACEUTICALS INC position peaked at $250K in Q2 2013.
40 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2016.

Based on Algert Global's 13F filing for Q1 2016, filed 10 May 2016.